Showing results (681-690 of 758) with videos related to

Sort By:
Pageof 76
The Lancet. Diabetes & Endocrinology|November 7, 2017
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trialAneliya Parvanova, Matias Trillini, Manuel A Podestà, et al.
International Journal of Public Health|May 31, 2024
Corrigendum: Time-Trends in Air Pollution Impact on Health in Italy, 1990-2019: An Analysis from the Global Burden of Disease Study 2019Sara Conti, Carla Fornari, Pietro Ferrara, et al.
International Journal of Public Health|June 22, 2023
Time-Trends in Air Pollution Impact on Health in Italy, 1990-2019: An Analysis From the Global Burden of Disease Study 2019Sara Conti, Carla Fornari, Pietro Ferrara, et al.
Drugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.
European Journal of Preventive Cardiology|August 1, 2015
Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markersBauke Schievink, Dick de Zeeuw, Paul A Smink, et al.
The New England Journal of Medicine|September 17, 2010
Erythropoietic response and outcomes in kidney disease and type 2 diabetesScott D Solomon, Hajime Uno, Eldrin F Lewis, et al.
Blood|August 19, 2020
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working groupFadi Fakhouri, Marie Scully, François Provôt, et al.
Iscience|September 21, 2023
A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by NeanderthalsMatteo Breno, Marina Noris, Nadia Rubis, et al.
Kidney International|June 5, 2014
Taming the chronic kidney disease epidemic: a global view of surveillance effortsJai Radhakrishnan, Giuseppe Remuzzi, Rajiv Saran, et al.
Plos Medicine|July 14, 2021
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) studyPiero Ruggenenti, Monica Cortinovis, Aneliya Parvanova, et al.
Pageof 76